文献速递膀胱癌与上尿路尿路上皮癌

膀胱影像报告和数据系统在伴组织学变异膀胱尿路上皮癌中的诊断价值

Diagnostic Value of the Vesical Imaging-Reporting and Data System in Bladder Urothelial Carcinoma with Variant Histology.
PubMed 文献 · Eur Urol Oncol · 2022-08-04

本研究回顾性纳入2011至2019年间接受多参数磁共振成像的360例膀胱癌患者(255例纯尿路上皮癌,69例组织学变异尿路上皮癌),评估膀胱影像报告和数据系统(VI-RADS)诊断肌层浸润性膀胱癌的价值。组织学变异组VI-RADS评分显著高于纯尿路上皮癌组(p<0.05),但122对配对患者中两组评分分布无显著差异(p>0.05);总体VI-RADS评分诊断肌层浸润的曲线下面积在纯尿路上皮癌为0.93-0.94,在组织学变异尿路上皮癌为0.89-0.92,两组间无显著差异(p=0.32-0.60)。

要点

  • 组织学变异组VI-RADS评分显著高于纯尿路上皮癌组(p<0.05)。
  • 配对后两组VI-RADS评分分布无显著差异(p>0.05)。
  • VI-RADS诊断肌层浸润的曲线下面积:纯尿路上皮癌0.93-0.94,组织学变异0.89-0.92,无显著差异(p=0.32-0.60)。

核心结论

  • VI-RADS评分在纯尿路上皮癌和组织学变异尿路上皮癌中检测肌层浸润均达到高诊断性能。

研究设计与样本

  • 回顾性评估2011至2019年间接受多参数磁共振成像的360例连续膀胱癌患者,其中纯尿路上皮癌255例,组织学变异尿路上皮癌69例。
  • 由四名阅片者分配VI-RADS评分,并在122对配对患者中比较两组评分分布。

主要发现

  • 组织学变异组VI-RADS评分显著高于纯尿路上皮癌组(p<0.05)。
  • 在122对配对患者中,所有阅片者报告的纯尿路上皮癌组与组织学变异组VI-RADS评分分布无显著差异(p>0.05)。
  • 总体VI-RADS评分诊断肌层浸润性膀胱癌的曲线下面积:纯尿路上皮癌为0.93-0.94,组织学变异尿路上皮癌为0.89-0.92,两组间无显著差异(p=0.32-0.60)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The value of the Vesicle Imaging-Reporting and Data System (VI-RADS) in the diagnosis of muscle-invasive bladder cancer (MIBC) for urothelial carcinoma with variant histology (VUC) remains unknown. We retrospectively evaluated 360 consecutive patients with bladder cancer (255 pure urothelial carcinoma [PUC] and 69 VUC) who underwent multiparametric magnetic resonance imaging between 2011 and 2019. VI-RADS scores assigned by four readers were significantly higher for the VUC group than for the PUC group (p < 0.05). In the cohort of 122 pair-matched patients, there was no significant difference in VI-RADS score distribution between the PUC and VUC groups for all readers (p > 0.05). The area under the receiver operating characteristic curve for MIBC diagnosis via overall VI-RADS score was 0.93-0.94 for PUC and 0.89-0.92 for VUC, with no significant difference between the PUC and VUC groups (p = 0.32-0.60). These data suggests that VI-RADS scores achieved high diagnostic performance for detection of muscle invasion in both PUC and VUC. PATIENT SUMMARY: The Vesical Imaging-Reporting and Data System (VI-RADS) is a standardized system for reporting on detection of muscle-invasive bladder cancer via magnetic resonance imaging (MRI) scans. Our study shows that VI-RADS is also highly accurate for diagnosis for different variants of muscle-invasive bladder cancer, with good inter-reader agreement.

来源:Eur Urol Oncol,查看原文。版权归原作者所有。

引用

  1. Arita Y, Yoshida S, Shigeta K, et al. Diagnostic Value of the Vesical Imaging-Reporting and Data System in Bladder Urothelial Carcinoma with Variant Histology. Eur Urol Oncol. 2022. PMID: 35933266. doi:10.1016/j.euo.2022.07.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。